Full Year 2023 Investor Presentation
112
Investor presentation
Full year 2023
Growth momentum has increased driven by demographics and
utilisation of full product portfolio
International Operations is diverse and
covers 190 markets
>487m
live with diabetes
16
>600m live with obesity
IO's share of revenue FY 2023
NAO
59%
41%
ΙΟ
%
Historic sales growth in IO
Value %
16%
30%
اااا.
8
6%
4
12
Growth momentum in IO
Novo NordiskⓇ
28%
20%
14%
10%
6%
0%
0
2016
2023
Nov
Nov
2020
2023
Growth rate range
NN Diabetes market share
-Market growth
NN Diabetes growth
NAO: North America Operations; IO: International Operations; FY: Full Year
Note: Share of Growth not depicted due to high numbers
Source (RHS): IQVIA Nov 2023, Value, MAT; Market values are based on the list prices. Source (LHS): Diabetes Atlas 10th editionView entire presentation